|
Jan 29
|
16 Most Undervalued Quality Stocks To Buy According To Hedge Funds
|
|
Jan 26
|
How To Invest: The Slow Saucer Base Can Produce Quick Returns
|
|
Jan 24
|
Biotech Stock Roundup: GILD Down on Study Results, INBX Gains on Sanofi Deal & More
|
|
Jan 23
|
Gilead Sciences (GILD) Outperforms Broader Market: What You Need to Know
|
|
Jan 23
|
Gilead Sciences to Release Fourth Quarter & Full Year 2023 Financial Results on Tuesday, February 6, 2024
|
|
Jan 23
|
Gilead (GILD) Down as NSCLC Study Fails to Meet Primary Goal
|
|
Jan 23
|
Gilead Sciences: Art Captures the Experiences of Women Living With Metastatic Breast Cancer
|
|
Jan 23
|
FDA Demands "Boxed Warning" to CAR T-Cell Therapy Labels
|
|
Jan 23
|
UPDATE 3-US FDA requires 'boxed warning' for CAR-T cancer therapies
|
|
Jan 23
|
US FDA requires 'boxed warning' for CAR-T cancer therapies
|
|
Jan 22
|
Why Gilead Sciences Stock Got Mashed on Monday
|
|
Jan 22
|
Is Gilead's 10% Crash — Resulting In A Failed Breakout — An Overreaction?
|
|
Jan 22
|
Gilead Sciences, Citi, Digital World Acquisition: Top Stocks
|
|
Jan 22
|
Gilead Stock Plunges On Disappointing Cancer Drug Study
|
|
Jan 22
|
Why Is HIV Drug Giant Gilead Stock Falling Monday?
|
|
Jan 22
|
Gilead Stock Tumbles on Cancer Drug Disappointment
|
|
Jan 22
|
Gilead Sinks After Lung Cancer Drug Fails to Improve Survival
|
|
Jan 22
|
Gilead Provides Update on Phase 3 EVOKE-01 Study
|
|
Jan 22
|
Gilead says Trodelvy fails to meet primary goal in 2nd-line lung cancer trial
|
|
Jan 22
|
Gilead drops 11% after lung cancer drug trial fails, analysts say stock is 'overreacting'
|